Clinical evidence - Non-metastatic prostate cancer

被引：0
|
作者：
Wilt, TJ
Brawer, MK
机构：
[1] NW Prostate Inst, Seattle, WA 98133 USA
[2] Minneapolis VA Hosp, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA
来源：
WESTERN JOURNAL OF MEDICINE | 1999年 / 171卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article comes from Clinical Evidence, a new resource for clinicians, produced jointly by the BMJ Publishing Group and the American College of Physicians-American Society of Internal Medicine. Clinical Evidence is an extensively peer-reviewed publication that summarizes the best available evidence on the effects of common clinical interventions gleaned from thorough searches and appraisal of the world literature. The first issue is available in book form in the United Kingdom, with a United States version planned for publication in October. The second issue, updated and expanded to cover more topics and questions, will be published 6 months later. Please see the advertisement For more information or visit our web site at www.evidence.org.
引用
收藏
页码：97 / 101
页数：5
相关论文
共 50 条
  • [1] Recommendations for clinical practice -: Therapeutic treatment of non-metastatic prostate cancer
    Soulie, M.
    Beuzeboc, P.
    Richaud, P.
    Villers, A.
    Kassab-Chahmi, D.
    Bataillard, A.
    Cornud, F.
    de Fromont, M.
    Gravis, G.
    Hennequin, C.
    Molinie, V.
    Mongiat-Artus, P.
    Muratet, J-P.
    du Chatelard, P-M. Pabot
    Prapotnich, D.
    Rebillard, X.
    Rossi, D.
    BULLETIN DU CANCER, 2006, 93 (10) : 1007 - 1015
  • [2] Role of bisphosphonates in non-metastatic prostate cancer
    Saad, Fred
    LANCET ONCOLOGY, 2014, 15 (10): : 1041 - 1042
  • [3] Combination hormone therapy for non-metastatic prostate cancer
    Ohlmann, Carsten
    Grunwald, V.
    Hadaschik, B.
    UROLOGIE, 2022, 61 (06): : 660 - 662
  • [4] STAMPEDE trial and patients with non-metastatic prostate cancer
    Gandaglia, Giorgio
    Fossati, Nicola
    Suardi, Nazareno
    Montorsi, Francesco
    Briganti, Alberto
    LANCET, 2016, 388 (10041): : 234 - +
  • [5] Economic evaluation of the treatments of non-metastatic prostate cancer
    Perlbarg, J.
    Rabetrano, H.
    Soulie, M.
    Salomon, L.
    Durand-Zaleski, I.
    PROGRES EN UROLOGIE, 2015, 25 (15): : 1108 - 1115
  • [6] First UK experience of apalutamide in metastatic and non-metastatic prostate cancer outside of clinical trials.
    Das, Prantik
    Mohammed, Rania
    Sarwar, Naveed
    Din, Omar
    Jain, Ankit
    Davies, Jessica
    Mugunthan, Thangrarajh
    Nair, Ajith
    Ghose, Aruni
    Bandyopadhyay, Seheli
    Krishnappa, Roopesh
    Iyer, Pooja
    Jones, Lauren
    Vasdev, Nikhil
    Moldawa, Maja
    Devine, Rebecca
    Hughes, Robert
    Sharma, Anand
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [7] Risk factors for clinical fractures among men with non-metastatic prostate cancer.
    Duh, MS
    Smith, MR
    Boyce, SP
    Moyneur, E
    Raut, MR
    Brandman, J
    Sung, JC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 392S - 392S
  • [8] Clinical characteristics and survival outcomes in patients with a high PSA and non-metastatic prostate cancer
    Huang, Cheng-Yu
    Chen, Chung-Hsin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (01) : 181 - 186
  • [9] Clinical characteristics and outcomes for patients with non-metastatic castration-resistant prostate cancer
    Arnold, Peter
    Penaloza-Ramos, Maria Cristina
    Adedokun, Lola
    Rees, Sarah
    Lockhat, Mohamed
    Spary, Lisa
    Watkins, Alan
    Gnanapragasam, Vincent
    Crabb, Simon J.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer
    Rzhevskiy, Alexey S. S.
    Kapitannikova, Alina Y. Y.
    Butnaru, Denis V. V.
    Shpot, Evgeniy V. V.
    Joosse, Simon A. A.
    Zvyagin, Andrei V. V.
    Ebrahimi Warkiani, Majid
    BIOMEDICINES, 2022, 10 (12)
12345